F.D.A. Issues Warning of Cancer Risk Linked to CAR-T Therapies

Health
By Christina Jewett from NYT Health https://ift.tt/oTYJtfS
via IFTTT Cancer, Immunotherapy, Blood, Deaths (Fatalities), Genetic Engineering, Labeling and Labels (Product) The agency has reviewed reports of cancer patients whose treatments resulted in the development of secondary blood cancers. Several companies will be required to carry the new warning.

Comments

Popular posts from this blog

Should the Autism Spectrum Be Split Apart?

The Jarring Contradiction at the Heart of Kennedy’s Agenda